Jamieson is pleased to announce it has advised the management team of B Medical on the sale of the business from Navis Capital Partners to Azenta, Inc (Nasdaq: AZTA).
B Medical is one of the leading vaccine cold chain providers serving primarily fast-growing emerging markets, which require secure and reliable temperature-controlled storage and transport solutions. The portfolio includes vaccine transport systems with real-time monitoring solutions, medical refrigeration for ambient to -86°C temperatures, and blood management solutions. B Medical has an installed base of more than 500,000 units spanning approximately 150 countries across the globe.
Andrew Cox and Matthew Mowat advised the management team on the transaction.
